DJIA 16,805.41 127.51 0.76%
NASDAQ 4,483.72 30.92 0.69%
S&P 500 1,964.58 13.76 0.71%
market minute promo

MannKind Corp (NASDAQ: MNKD)

5.73 0.08 (1.42%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MNKD $5.73 1.42%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.60
Previous Close $5.65
Daily Range $5.52 - $5.74
52-Week Range $3.80 - $11.48
Market Cap $2.3B
P/E Ratio -8.56
Dividend (Yield) $0.00 (0.0%)
Volume 2,733,959
Average Daily Volume 6,231,803
Current FY EPS -$0.33

Sector

Healthcare

Industry

Drugs

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website: http://www.mannkindcorp.com/

News & Commentary

MannKind Corporation's Investors Shouldn't Dance Around This Issue

It's not a good sign that MannKind's competitor can't IPO.

MannKind: Massive Short Interest Could Lead To Big Gains

Goldman Sachs Analyst Neutral Rating of MannKind Feels Like Downgrade

MannKind: 5 Potential Technosphere Applications

Discovery Laboratories: Collaboration With Battelle Is Validation Of Aerosurf's Potential By A Sophi

Discovery Laboratories: Collaboration With Battelle Is Validation Of Aerosurf's Potential By A Sophisticated Third Party

Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents

MannKind (MNKD) Worth Watching: Stock Gains 12.9% - Tale of the Tape

Dance until the music stops: Insulin biotech Dance Biopharm withdraws $75 million IPO

The State Of MannKind

MannKind: Technosphere Is The Real Game Changer

See More MNKD News...

MNKD's Top Competitors

MNKD $5.73 (1.42%)
Current stock: MNKD
AMGN $147.26 (0.01%)
Current stock: AMGN
GILD $110.71 (3.29%)
Current stock: GILD
BIIB $321.67 (1.77%)
Current stock: BIIB